Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: Results from the PURSUIT trial

American Journal of Cardiology

Volumn 88, Issue 1, 2001, Pages 76-79

  Al Khatib, Sana M ^a   Pieper, Karen S ^a   Lee, Kerry L ^a   Mahaffey, Kenneth W ^a   Hochman, Judith S ^b   Pepine, Carl J ^c   Kopecky, Stephen L ^d   Akkerhuis, Martijn ^e   Stepinska, Janina ^f   Simoons, Maarten L ^g   Topol, Eric J ^h   Califf, Robert M ^a   Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e CARDIALYSIS   (Netherlands)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; EPTIFIBATIDE; HEPARIN; PLACEBO; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; PEPTIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STROKE; CEREBROVASCULAR ACCIDENT; FEMALE; MALE; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035400060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01593-4     Document Type: Article

References (17)

1. Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience
2. Atrial fibrillation in acute myocardial infarction: A prospective study based on data from a consecutive series of patients admitted to the coronary care unit
3. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: A community-wide perspective
4. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction
5. Early atrial arrhythmias in acute myocardial infarction. Role of the sinus node artery
6. The role of infarction-associated pericarditis on the occurrence of atrial fibrillation
7. Atrial fibrillation in inferior wall Q-wave acute myocardial infarction
8. Factors associated with atrial fibrillation in Q wave anterior myocardial infarction
9. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction
10. Paroxysmal atrial fibrillation and flutter associated with acute myocardial infarction: Hemodynamic evaluation in relation to the development of arrhythmias and prognosis
11. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
12. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients
13. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: Results from the GUSTO trial
14. Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase mortality trial: Variation by country beyond predictive value
15. Atrial fibrillation as an independent risk factor for stroke: The Framingham study
16. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study
17. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study